Towards the gene therapy of LAD-I immunodeficient patients

被引：0
|
作者：
Almarza, E. [1 ,2 ,3 ]
Mesa-Nunez, C. [1 ,2 ,3 ]
Damian, C. [1 ,2 ,3 ]
Leon-Rico, D. [1 ,2 ,3 ]
Aldea, M. [1 ,2 ,3 ]
Carrascoso, C. [1 ,2 ,3 ]
Lozano, M. L. [1 ,2 ,3 ]
Guenechea, G. [1 ,2 ,3 ]
Thrasher, A. J. [4 ]
Bueren, J. A. [1 ,2 ,3 ]
机构：
[1] Ctr Invest Energet Medioambientales & Tecnol CIEM, Div Haematopoiet Innovat Therapies, Madrid 28040, Spain
[2] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid 28040, Spain
[3] Fdn Jimenez Diaz IIS FJD UAM, Inst Invest Sanitaria, Adv Therapies Unit, Madrid, Spain
[4] Univ Coll London ICH UCL, Inst Child Hlth, Mol Immunol Unit, London WC1N 1EH, England
来源：
HUMAN GENE THERAPY | 2017年 / 28卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P010
引用
收藏
页码：A20 / A21
页数：2
相关论文
共 50 条
  • [11] Prenatal Diagnosis of LAD-I on Cord Blood by Flowcytometry
    Madkaikar, Manisha Rajan
    Gupta, Maya
    Rao, Meghana
    Ghosh, Kanjaksha
    INDIAN JOURNAL OF PEDIATRICS, 2012, 79 (12): : 1605 - 1609
  • [12] Leukocyte Adhesion Deficiency-I (LAD-I): A Comprehensive Review of Published Cases
    Kasbekar, Sanchali
    Bueren, Juan
    Thrasher, Adrian J.
    Kohn, Donald B.
    Sevilla, Julian
    Schwartz, Jonathan D.
    Almarza, Elena
    BLOOD, 2017, 130
  • [13] A Phase 1/2 Study of Lentiviral-mediated Ex-vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I): Interim Results
    Kohn, Donald
    Rao, Gayatri
    Almarza, Elena
    Terrazas, Dayna
    Nicoletti, Eileen
    Fernandes, Augustine
    Kuo, Caroline
    De Oliveira, Satiro
    Moore, Theodore
    Law, Ken
    Beard, Brian
    Sevilla, Julian
    Mesa-Nunez, Cristina
    Booth, Claire
    Thrasher, Adrian
    Bueren, Juan
    Schwartz, Jonathan
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (SUPPL 1) : S126 - S126
  • [14] A phase 1/2 study of lentiviral-mediated ex-vivo gene therapy for pediatric patients with severe leukocyte adhesion deficiency-I (LAD-I): Interim results
    Booth, C.
    Kohn, D. B.
    Sevilla, J.
    Rao, G. R.
    Almarza, E.
    Terrazas, D.
    Nicoletti, E.
    Fernandes, A.
    Kuo, C.
    De Oliveira, S.
    Moore, T. B.
    Law, K. M.
    Beard, B. C.
    Choi, G.
    Zeini, M.
    Mesa-Nunez, C.
    Thrasher, A. J.
    Bueren, J.
    Schwartz, J.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A5 - A5
  • [15] A Phase 1/2 Study of Lentiviral-Mediated Ex-Vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I): Interim Results
    Kohn, Donald B.
    Booth, Claire
    Sevilla, Julian
    Rao, Gayathri R.
    Almarza, Elena
    Terrazas, Dayna
    Nicoletti, Eileen
    Fernandes, Augustine
    Kuo, Caroline
    Oliveira, Satirode
    Moore, Theodore B.
    Law, Kenneth M.
    Beard, Brian C.
    Choi, Grace
    Zeini, Miriam
    Mesa-Nunez, Cristina
    Thrasher, Adrian J.
    Bueren, Juan A.
    Schwartz, Jonathan D.
    BLOOD, 2021, 138
  • [16] A Phase 1/2 Study of Lentiviral-Mediated Ex-Vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I): Interim Results
    Kohn, Donald B.
    Rao, Gayatri
    Almarza, Elena
    Terrazas, Dayna
    Nicoletti, Eileen
    Fernandes, Augustine
    Kuo, Caroline
    De Oliviera, Satiro
    Moore, Theodore
    Law, Ken
    Beard, Brian
    Sevilla, Julian
    Mesa-Nunez, Cristina
    Booth, Claire
    Thrasher, Adrian
    Bueren, Juan
    Schwartz, Jonathan
    MOLECULAR THERAPY, 2021, 29 (04) : 19 - 20
  • [17] Autologous Ex-Vivo Lentiviral Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I): Interim Results from an Ongoing Phase 1/2 Study
    Kohn, Donald B.
    Sevilla, Julian
    Rao, Gayatri
    Lopez, Maria Chitty
    Almarza, Elena
    Terrazas, Dayna
    Zubicaray, Josune
    Gonzalez-Vicent, Marta
    Chetty, Kritika
    O'Toole, Grainne
    Xu-Bayford, Jinhua
    Nicoletti, Eileen
    Fernandez, Augustine
    Kuo, Caroline Y.
    De Oliveira, Satiro N.
    Moore, Theodore B.
    Choi, Grace
    Zeini, Miriam
    Mesa-Nunez, Cristina
    Thrasher, Adrian J.
    Bueren, Juan A.
    Schwartz, Jonathan
    Booth, Claire
    MOLECULAR THERAPY, 2023, 31 (04) : 727 - 728
  • [18] Interim Results from an Ongoing Phase 1/2 Study of Lentiviral-Mediated Ex-Vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
    Kohn, D. B.
    Sevilla, J.
    Rao, G.
    Chitty Lopez, M.
    Almarza, E.
    Terrazas, D.
    Zubicaray, J.
    Gonzalez-Vicent, M.
    Chetty, K.
    O'Toole, G.
    Xu-Bayford, J.
    Nicoletti, E.
    Fernandes, A.
    Kuo, C.
    de Oliveira, S.
    Moore, T. B.
    Choi, G.
    Zeini, M.
    Mesa-Nunez, C.
    Thrasher, A. J.
    Bueren, J.
    Schwartz, J.
    Booth, C.
    MOLECULAR THERAPY, 2022, 30 (04) : 550 - 550
  • [19] Interim Results from an Ongoing Phase 1/2 Study of Lentiviral-mediated Ex-vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
    Booth, Claire
    Sevilla, Julian
    Rao, Gayatri R.
    Lopez, Maria Chitty
    Almarza, Elena
    Terrazas, Dayna
    Zubicaray, Josune
    Gonzalez Vicent, Marta
    Chetty, Kritika
    O'Toole, Grainne
    Xu-Bayford, Jinhua
    Nicoletti, Eileen
    Fernandes, Augustine
    Kuo, Caroline
    de Oliveira, Satiro
    Moore, Theodore B.
    Choi, Grace
    Zeini, Miriam
    Mesa-Nunez, Cristina
    Thrasher, Adrian J.
    Bueren, Juan A.
    Schwartz, Jonathan D.
    Kohn, Donald B.
    BLOOD, 2022, 140 : 7774 - 7775
  • [20] A Phase 1/2 Study of Lentiviral-Mediated Ex-Vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I): Results from Phase 1
    Kohn, Donald B.
    Rao, Gayatri R.
    Almarza, Elena
    Terrazas, Dayna
    Nicoletti, Eileen
    Fernandes, Augustine
    Kuo, Caroline
    De Oliveira, Satiro N.
    Moore, Theodore B.
    Law, Kenneth M.
    Beard, Brian C.
    Sevilla, Julian
    Mesa-Nunez, Cristina
    Bueren, Juan A.
    Schwartz, Jonathan D.
    BLOOD, 2020, 136
12345